Which stocks might be disrupted next by Ozempic and other GLP-1 drugs
GLP-1 medications could have far-reaching implications for a wide variety of conditions, from liver disease to sleep apnea to heart
Read MoreGLP-1 medications could have far-reaching implications for a wide variety of conditions, from liver disease to sleep apnea to heart
Read MoreThe firm said these stocks have downside support and enough cash on hand to buy back shares or acquire companies
Read MoreDan Loeb's hedge fund expects the retailer can resolve many of its issues by bringing more experience to Bath &
Read MoreThese are the stocks posting the largest moves in midday trading. Source link
Read More